Advertisement

Topics

Embera NeuroTherapeutics Inc. Company Profile

08:08 EST 16th February 2019 | BioPortfolio

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions related to stress response that drive craving and relapse associated with these disorders. Embera is advancing EMB-001 development programs in smoking cessation and cocaine dependence. Embera is supported by Louisiana Fund I and BVM Capital.


News Articles [19 Associated News Articles listed on BioPortfolio]

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal

Supernus Pharmaceutical, headquartered in Rockville, Maryland, is acquiring Biscayne Neurotherapeutics, located in Miami, Florida.

$SUPN to Acquire Biscayne Neurotherapeutics. M&A here we go.. https://globenewswire.com/news-release/2018/09/13/1570828/0/en/Supernus-to-Acquire-Biscayne-Neurotherapeutics.html …

$SUPN to Acquire Biscayne Neurotherapeutics. M&A here we go.. https://globenewswire.com/news-release/2018/09/13/1570828/0/en/Supernus-to-Acquire-Biscayne-Neurotherapeutics.html …

Supernus acquires epilepsy start-up Biscayne Neurotherapeutics for up to $183mm

Supernus Pharmaceuticals Inc. agreed to acquire epilepsy-focused start-up Biscayne Neurotherapeutics Inc. (BNT) for up to $183mm.

Supernus Gains Epilepsy Drug through Acquisition of Biscayne Neurotherapeutics

ROCKVILLE, Md., Sept. 13, 2018 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment ...

Supernus to Acquire Biscayne Neurotherapeutics

Adds Phase 1 Novel Epilepsy Development Program ROCKVILLE, Md., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a pharmaceutical company focused on developing and...

Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal http://dlvr.it/QkBxsD pic.twitter.com/wbIReBAQrT

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal http://dlvr.it/QkBxsD  pic.twitter.com/wbIReBAQrT

Supernus Pharmaceuticals ($SUPN) to Acquire Biscayne Neurotherapeutics, Adding #Epilepsy Candidate: http://ow.ly/Q6DP30lP4zt pic.twitter.com/PpMc08waKC

Supernus Pharmaceuticals ($SUPN) to Acquire Biscayne Neurotherapeutics, Adding #Epilepsy Candidate: http://ow.ly/Q6DP30lP4zt  pic.twitter.com/PpMc08waKC

Drugs and Medications [0 Results]

None

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Targeting the Neuromuscular Junction in ALS.

Abstracts from HSG 2018.

Why Microtubules Should Be Considered as One of the Supplementary Targets for Designing Neurotherapeutics.

In the past decade of research, drugs targeting amyloid beta (Aβ) have failed in clinical amelioration of Alzheimer's disease (AD). This has led to researchers searching for more attractive targets. ...

How would we combat menopause as an Alzheimer's risk factor?

Automatic Removal of False Connections in Diffusion MRI Tractography Using Topology-Informed Pruning (TIP).

Diffusion MRI fiber tracking provides a non-invasive method for mapping the trajectories of human brain connections, but its false connection problem has been a major challenge. This study introduces ...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Cognitive Training for PTSD

Posttraumatic stress disorder (PTSD) is a chronic, disabling condition that occurs in a subgroup of individuals after experiencing traumatic stress, and is common in Veterans seeking menta...

Companies [6 Associated Companies listed on BioPortfolio]

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range ...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorder...

System1 Biosciences, Inc.

System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric di...

Tetra Discovery Partners Inc.

Tetra Discovery Partners is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Alzhe...

More Information about "Embera NeuroTherapeutics Inc." on BioPortfolio

We have published hundreds of Embera NeuroTherapeutics Inc. news stories on BioPortfolio along with dozens of Embera NeuroTherapeutics Inc. Clinical Trials and PubMed Articles about Embera NeuroTherapeutics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embera NeuroTherapeutics Inc. Companies in our database. You can also find out about relevant Embera NeuroTherapeutics Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record